Unexplained weight loss (UWL), a multifaceted challenge, often perplexes clinicians due to its myriad potential causes.
Comprehensive history taking, physical examination, and targeted investigations are pivotal. A meticulous approach can unveil underlying malignancies, endocrine disorders, or gastrointestinal diseases.
Imaging modalities like CT and PET scans can be instrumental in diagnosing occult malignancies causing UWL.
UWL evaluation requires a systematic approach, integrating clinical acumen with appropriate investigations. Continued medical research is essential to refine our understanding and management of this complex phenomenon.
1.
Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer
2.
Acupuncture may alleviate nocturia in men treated for prostate cancer
3.
Inadvertent lung cancer screening results are discussed in a new study.
4.
Patients face high out-of-pocket costs after incident cancer diagnosis
5.
Rucaparib Delays Next Lines of Therapy in Ovarian Cancer
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
3.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
4.
Unveiling the Mystery Behind Lymphovascular Invasion
5.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation